Apple peptides may speed skin healing after cosmetic procedures

NCT ID NCT07807085

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 08, 2026 · Last updated Sep 09, 2026 · Updated 1 time

Summary

This trial tests a topical apple peptide complex for improving skin recovery after aesthetic procedures such as liposuction, breast augmentation, laser treatments, and microneedling. Women aged 45 to 65 who have had or are planning such procedures will apply the product to their skin and be compared to a control group. Researchers will measure skin redness, dryness, moisture retention, and comfort to see if the product supports healing and improves appearance.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A topical formulation containing apple peptides, applied to the skin after aesthetic procedures.
What this could lead to
If effective, this topical product could become a standard part of post-procedure care to improve skin recovery and appearance.
What could go wrong
This is a small early-stage trial, and results may not apply to all skin types or procedures. The product is cosmetic, so benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Jan 2021

Finished

Dec 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female participants aged 45-65 years * Undergoing or have undergone aesthetic or surgical procedures (e.g., liposuction, breast augmentation, laser treatments, microneedling) * Presence of skin concerns such as hyperpigmentation, scarring, or reduced elasticity * Willing and able to comply with study procedures and follow-up * Physician clearance for participation Exclusion Criteria: * Active skin infections, open wounds, or delayed wound healing * Pregnancy or breastfeeding * Use of conflicting topical or systemic treatments * Known allergy to botanical ingredients in the formulation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast augmentation and breast reconstruction are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hyperpigmentation hyperpigmentation of the skin Lymphatic Abnormalities Skin Abnormalities skin disorder Striae Distensae

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Grow Out Oils Clinical Aromatherapy Company

    Weston, Florida, 33326, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.